NCT06442852View on ClinicalTrials.gov

Study on the Relationship Between Peripheral Blood miRNA and Risk and Severity of Alzheimer's Disease

RecruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

April 3, 2021

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions

Alzheimer DiseaseMicroRNAs

Interventions

OTHER

exposure

The observed exposure factor was the expression level of synaptic associated mirna in the serum of patients with Alzheimer's disease and healthy volunteers

Trial Locations (1)

430000

RECRUITING

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors

lead

Jiajie Chen

OTHER